Antibody Able to Block Protein That Promotes PAH and May Bolster Existing Therapies, Study Finds

An antibody that recognizes and blocks the activity of osteoprotegerin, a protein involved in the development of pulmonary arterial hypertension (PAH), was able to stop and even reverse disease progression in animal and cell models of PAH, a study reports. The study, "A therapeutic antibody...